Surprising culprit behind chemo resistance in rare cancer
Researchers led by Michael H. Tomasson, MD, at Washington University School of Medicine in St. Louis have shown how an aggressive form of multiple myeloma resists chemotherapy. Multiple myeloma is a rare cancer of plasma cells in the bone marrow. Though the finding has no immediate benefit for patients, the scientists say it could help guide research into better treatments.